Valion Bio, Inc. (VBIO)
1.17
-0.06
(-4.88%)
USD |
NASDAQ |
Oct 16, 16:00
1.14
-0.03
(-2.56%)
After-Hours: 20:00
Valion Bio EPS Diluted (Quarterly) : -52.54 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -52.54 |
| March 31, 2026 | -53.77 |
| September 30, 2025 | -49.14 |
| June 30, 2025 | -54.78 |
| March 31, 2025 | -65.95 |
| December 31, 2024 | -66.30 |
| September 30, 2024 | -98.23 |
| June 30, 2024 | -134.19 |
| March 31, 2024 | -428.84 |
| December 31, 2023 | -650.22 |
| September 30, 2023 | -628.66 |
| June 30, 2023 | -3043.00 |
| March 31, 2023 | -4469.30 |
| Date | Value |
|---|---|
| December 31, 2022 | -9898.25 |
| September 30, 2022 | -11347.50 |
| June 30, 2022 | -13330.97 |
| March 31, 2022 | -9799.22 |
| December 31, 2021 | -16291.10 |
| September 30, 2021 | -38244.05 |
| June 30, 2021 | -5018.40 |
| March 31, 2021 | -6219.88 |
| December 31, 2020 | -5123.80 |
| September 30, 2020 | -4288.68 |
| June 30, 2020 | -2683.45 |
| March 31, 2020 | -4596.38 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Outlook Therapeutics, Inc. | -0.1486 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.057M |
| Total Expenses (Quarterly) | 7.057M |
| Enterprise Value | 23.13M |
| Earnings Yield | -17.97K% |
| Normalized Earnings Yield | -18005.50 |